Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Reducing unnecessary screening mammograms for women 75 and older

Official title: De-implementation of Overuse of Mammography Screening in Older Racially and Ethnically Diverse Women

Run by Columbia University · NCT07511621 · Data updated 2026-11-12

This project tests a multilevel approach to help doctors and patients decide whether to stop routine mammograms for women aged 75 and older.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMarch 11, 2026
Main results expectedMarch 2028
Study endsMarch 2028
Registry record updatedSeptember 25, 2026
Trial IDNCT07511621 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

English- or Spanish-speaking women aged 75 or older who have a primary care visit scheduled in the next 2–4 weeks and who had a screening mammogram 7–18 months earlier but not in the past 6 months, and who do not have a history of breast cancer, atypical ductal hyperplasia, or dementia.

Probably not a fit

Women with a history of breast cancer or atypical ductal hyperplasia, those with dementia, or those who recently had a screening or require diagnostic mammography are unlikely to benefit from this de-implementation approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The team used a participatory stakeholder-driven innovation tournament and a discrete choice experiment to design a tailored multilevel de-implementation strategy targeting routine screening mammography in women aged 75 and older. Organizational components of the strategy will be rolled out for all sites, while provider- and patient-level components will be tested in a cluster randomized trial at the provider level. Primary outcomes are changes in screening mammography use and provider orders/referrals, with secondary analyses of implementation processes and contextual factors. The project aims both to reduce low-value care for older women and to advance methods for selecting and testing de-implementation strategies.

Why it matters

Potential benefit: If successful, the approach could reduce unnecessary mammograms and the related harms of false positives, anxiety, and invasive follow-up for older women.

How similar studies have gone: De-implementation research is relatively new and few randomized trials have tested multilevel strategies to reduce screening mammography overuse, so this approach is fairly novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patient level criteria

Inclusion criteria

* English- or Spanish-speaking women based on preferred language in electronic health record
* Aged 75 and older at the time of their scheduled primary care visit
* Women who have a primary care visit scheduled within the next 2-4 weeks
* Women who have not had a screening mammogram 6 months prior to their scheduled primary care visit but have had a screening mammogram 7-18 months prior to their scheduled primary care visit

Exclusion Criteria

* Women with a history of atypical ductal hyperplasia (ADH) or non-invasive or invasive breast cancer (assessed via ICD 10 code)
* Women with dementia (assessed via ICD 10 code)
* ICD codes to use across exclusion criteria: F01-F03, Z85.3, G30-G31, N60, C50, or D05

Provider level criteria

Inclusion Criteria

• Primary care clinicians attributed to the 2 intervention clinics that serve adult patients, including those ≥75 years

Exclusion Criteria

* Specialists
* Primary care clinicians for patients \< 18 years old
* Non-clinicians
* Physician assistants

Where it's running

  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.